Clinical trials
Observational Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Poitiers University Hospital | 3 |
| University Hospital, Bordeaux | 3 |
| Bristol-Myers Squibb | 2 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 2 |
| Novartis Pharmaceuticals | 2 |
| Hospices Civils de Lyon | 1 |
| Incyte BioSciences France | 1 |
| Institut Bergonié | 1 |
| University Hospital, Angers | 1 |
| University Hospital, Caen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 19 |
| Leukemia | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Breast Neoplasms | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Colonic Neoplasms | 1 |
| Hematologic Diseases | 1 |
| Hematologic Neoplasms | 1 |
| Kidney Neoplasms | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.